The Finnish Pain Association has been chosen to the Fimea (Finnish Medicines Agency) Patient Advisory Board 2020-2022
The Advisory Board’s operation aims to incorporate patient perspectives in official duties and to make it possible to take them into account in Fimea’s operation; establish direct communication between Fimea and patient and disability organisations and to strength the flow of information between them; increase the transparency of regulatory operations and awareness of them, and increase expert communication and reliable information.
The matters discussed by the patient advisory board in its meetings are related to Fimea’s operations and tasks. The topics of the meetings are planned jointly according to the wishes and needs of Fimea’s officials and the members of the advisory board.
